Kyverna Therapeutics (KYTX) Stock Insights

KYTX price $5.81 +0.18 +3.20%

Ticker
KYTX
Price
$5.81
Change
+0.18 +3.20%
Market cap ?
$359.31M
Beta ?
2.06
Sector
Healthcare
Industry
Biotechnology

Fair value

KYTX fair value Not meaningful. Price $5.81.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare KYTX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-11—-0.68——
2026-08-12-0.63-0.68——
2026-05-12-0.66-0.75——
2026-03-26-0.80-0.84——
2025-11-12-0.85-0.97——
2025-08-12-0.97-1.00——
2025-05-13-1.03-1.21——
2025-03-27-0.88-0.87——
2024-11-13-0.80-0.77——
2024-08-12-0.67-0.70——
2024-05-14-1.12-0.88——
2024-03-26-26.86-3.23—3.75M
2023-09-30-0.36———
2023-06-30-0.30———
2023-03-31-0.43———
2022-12-31-0.20—282.00K—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-05-27CLARK IAN TBuy5.09K——
2026-05-27CLARK IAN TBuy20.58K$8.59176.80K
2026-05-27Cohen Fred EBuy5.09K——
2026-05-27Cohen Fred EBuy20.58K$8.59176.80K
2026-05-27SEIDENBERG BETH CBuy5.09K——
2026-05-27SEIDENBERG BETH CBuy20.58K$8.59176.80K
2026-05-27Shaw ChristiSell4.19K$8.5936.03K
2026-05-27Aktar MertBuy5.09K——
2026-05-27Aktar MertBuy20.58K$8.59176.80K
2026-05-18Martini Gregory S.Buy325.00K$8.542.78M
2026-05-18Martini Gregory S.Other0——
2026-05-04Dac NadiaBuy300.00K$9.002.70M
2026-05-04Dac NadiaOther0——
2026-03-13GRASSO MARCBuy65.00K$8.95581.75K
2026-03-13GRASSO MARCBuy10.00K——
2026-03-13Biddle Warner WestonBuy350.00K$8.953.13M
2026-03-13Biddle Warner WestonBuy58.00K——
2026-03-13GEHCHAN NAJIBuy105.00K$8.95939.75K
2026-03-13GEHCHAN NAJIBuy18.00K——
2026-02-24Miller Andrew CraigOther0——
2026-02-24Miller Andrew CraigBuy42.95K$7.95341.41K
2026-02-24Miller Andrew CraigBuy11.01K——
2026-02-24Emany Sravan KumarBuy42.95K$7.95341.41K
2026-02-24Emany Sravan KumarBuy11.01K——
2026-02-24Emany Sravan KumarOther0——
2026-02-09Pujols MayobanexOther0——
2026-02-09Pujols MayobanexBuy300.00K$8.082.42M
2026-01-12Shaw ChristiBuy185.00K$8.231.52M
2026-01-12Shaw ChristiBuy24.30K——
2026-01-12Shaw ChristiBuy30.00K——
2025-12-18SEIDENBERG BETH CBuy133.33K$7.501000.00K
2025-12-18Westlake BioPartners Opportunity Fund I, L.P.Buy133.33K$7.501000.00K
2025-12-15Walker Karen MarieSell24.00K$4.83115.91K
2025-12-15Walker Karen MarieBuy24.00K$4.83115.91K
2025-12-15Walker Karen MarieSell24.00K$12.20292.78K
2025-06-30GRASSO MARCSell450.00K$3.071.38M
2025-06-30GRASSO MARCOther0——
2025-05-29Shaw ChristiBuy65.35K$2.63171.87K
2025-05-29Shaw ChristiBuy16.63K——
2025-05-29SEIDENBERG BETH CBuy65.35K$2.63171.87K
2025-05-29SEIDENBERG BETH CBuy16.63K——
2025-05-29SPIEGELMAN DANIEL KBuy65.35K$2.63171.87K
2025-05-29SPIEGELMAN DANIEL KBuy16.63K——
2025-05-29Aktar MertBuy65.35K$2.63171.87K
2025-05-29Aktar MertBuy16.63K——
2025-05-29CLARK IAN TBuy65.35K$2.63171.87K
2025-05-29CLARK IAN TBuy16.63K——
2025-05-29Cohen Fred EBuy65.35K$2.63171.87K
2025-05-29Cohen Fred EBuy16.63K——
2025-04-11Jones Ryan AlexanderBuy12.00K——
2025-04-11Walker Karen MarieBuy13.00K——
2025-02-14Shaw ChristiBuy38.68K$3.03117.20K
2025-01-22GEHCHAN NAJIBuy425.00K$3.291.40M
2025-01-22GEHCHAN NAJIOther0——
2024-10-21Aktar MertBuy87.74K$5.20456.25K
2024-10-21Aktar MertOther0——
2024-09-16Biddle Warner WestonBuy2.58M$6.8917.77M
2024-09-16Shaw ChristiBuy66.59K$6.89458.82K
2024-09-16Biddle Warner WestonOther0——
2024-09-16Shaw ChristiOther0——
2024-06-06Walker Karen MarieSell9.64K$4.4242.59K
2024-06-06Walker Karen MarieBuy9.64K$4.4242.59K
2024-05-28Jones Ryan AlexanderBuy7.15K$0.735.22K
2024-05-28Jones Ryan AlexanderBuy10.87K$0.737.94K
2024-05-28Jones Ryan AlexanderSell7.15K$0.735.22K
2024-05-28Jones Ryan AlexanderSell10.87K$0.737.94K
2024-04-11Biddle Warner WestonBuy332.50K$2.06684.95K
2024-04-11Jones Ryan AlexanderBuy74.00K$2.06152.44K
2024-04-11Walker Karen MarieBuy80.00K$2.06164.80K
2024-02-12Vida Ventures, LLCBuy4.52M——
2024-02-12Vida Ventures, LLCBuy252.55K$22.005.56M
2024-02-12Vida Ventures, LLCBuy583$22.0012.83K
2024-02-12Vida Ventures, LLCSell8.83M——
2024-02-12Vida Ventures, LLCSell4.40M——
2024-02-12Vida Ventures, LLCSell7.36M——
2024-02-12Cohen Fred EBuy4.52M——
2024-02-12Cohen Fred ESell4.40M——
2024-02-12Cohen Fred ESell8.83M——
2024-02-12Cohen Fred ESell7.36M——
2024-02-12SEIDENBERG BETH CBuy3.79M——
2024-02-12SEIDENBERG BETH CBuy735.98K——
2024-02-12SEIDENBERG BETH CSell8.83M——
2024-02-12SEIDENBERG BETH CSell4.40M——
2024-02-12SEIDENBERG BETH CSell3.35M——
2024-02-12Westlake BioPartners Fund I, L.P.Buy3.79M——
2024-02-12Westlake BioPartners Fund I, L.P.Buy735.98K——
2024-02-12Westlake BioPartners Fund I, L.P.Sell3.35M——
2024-02-12Westlake BioPartners Fund I, L.P.Sell8.83M——
2024-02-12Westlake BioPartners Fund I, L.P.Sell4.40M——
2024-02-12Bain Capital Life Sciences Investors, LLCBuy450.00K$22.009.90M
2024-02-12Bain Capital Life Sciences Investors, LLCBuy2.71M——
2024-02-12Bain Capital Life Sciences Investors, LLCSell12.35M——
2024-02-12GILEAD SCIENCES, INC.Buy910.00K$22.0020.02M
2024-02-12GILEAD SCIENCES, INC.Buy3.22M——
2024-02-12GILEAD SCIENCES, INC.Sell7.75M——
2024-02-12GILEAD SCIENCES, INC.Sell6.89M——
2024-02-12Northpond Ventures III GP, LLCBuy2.81M$0.0028
2024-02-12Northpond Ventures III GP, LLCBuy450.00K$22.009.90M
2024-02-12Northpond Ventures III GP, LLCSell12.77M——
2024-02-07Liapis Stephen ConstantineOther0——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 128, holders +12 vs prior quarter. Ownership 62.28%.

HolderSharesChangeChange %Value
GORDONMD GLOBAL INVESTMENTS LP4.24M00.00%37.82M
GILEAD SCIENCES, INC.4.13M00.00%36.76M
BLACKROCK, INC.3.13M2.26M+257.41%27.93M
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC2.88M-225.00K-7.23%25.71M
AIGH CAPITAL MANAGEMENT LLC2.80M795.80K+39.79%24.91M
DEERFIELD MANAGEMENT COMPANY, L.P.2.00M00.00%17.82M
VANGUARD CAPITAL MANAGEMENT LLC1.90M114.11K+6.40%16.91M
PRICE T ROWE ASSOCIATES INC /MD/1.19M-369.26K-23.74%10.57M
GEODE CAPITAL MANAGEMENT, LLC1.05M625.60K+147.61%9.35M
INSIGHT HOLDINGS GROUP, LLC989.05K00.00%8.81M
MORGAN STANLEY982.31K5.02K+0.51%8.75M
STATE STREET CORP982.23K843.93K+610.22%8.75M
PROPEL BIO MANAGEMENT, LLC883.20K238.78K+37.05%7.87M
WOODLINE PARTNERS LP845.33K00.00%7.53M
MILLENNIUM MANAGEMENT LLC639.78K-365.73K-36.37%5.70M
MBB PUBLIC MARKETS I LLC614.48K00.00%5.47M
ADAGE CAPITAL PARTNERS GP, L.L.C.500.00K00.00%4.46M
D. E. SHAW & CO., INC.469.35K-252.24K-34.96%4.18M
WELLS FARGO & COMPANY/MN373.01K258.61K+226.06%3.32M
UBS GROUP AG365.57K-84.18K-18.72%3.26M
GOLDMAN SACHS GROUP INC335.23K122.32K+57.45%2.99M
RENAISSANCE TECHNOLOGIES LLC333.90K-33.59K-9.14%2.98M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.319.67K319.67KNew2.85M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC319.67K108.58K+51.44%2.85M
NORTHERN TRUST CORP315.35K237.31K+304.08%2.81M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Kyverna Therapeutics (KYTX) Stock Insights

KYTX$5.81+0.18 +3.20%

$359.31M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History